1 |
Panico FG, Neptune WB. A mechanism to eliminate the donor blood prime from the pump oxygenator. Surg Forum 1960;10:605-9
|
2 |
Horrow JC, Hlavacek J, Strong MD, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 1990;99:70-4
|
3 |
DeBois WJ, Sukhram Y, McVey J, et al. Reduction in homologous blood transfusions using a low prime circuit. J Extracorporeal Technol 1996;28:58-62
|
4 |
Surgenor DM, Wallace EL, Churchill WH, Hao SHS, Chapman RH, Collins JJ. Red cell transfusions in coronary artery bypass surgery (DRGs 106 & 107). Transfusion 1992;32: 458-64
DOI
ScienceOn
|
5 |
Belisle S, Hardy J-F. Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg 1996;62:1908-17
DOI
ScienceOn
|
6 |
Jansen PG, te Velthuis H, Bulder ER, et al. Reduction in prime volume attenuates the hyperdynamic response after cardiopulmonary bypass. Ann Thorac Surg 1995;60:544-50
DOI
ScienceOn
|
7 |
Rosengart TK, DeBois WJ, O'Hara M, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg 1998;115:426-39
DOI
ScienceOn
|
8 |
Gravlee GP, Davis RF, Kurusz M, Utley JR. Cardiopulmonary Bypass; principles and practice. 2nd ed. p 186-196. Philadelphia, PA, USA. Lippincott Williams & Wilkins Co. 2000
|
9 |
Casas JI, Zuazu-Jausoro I, Mateo J, Oliver A, Litvan H, Muniz-Diaz E, et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass: a double-blind placebo-controlled study. J Thorac Cardiovasc Surg 1995;110:1107-17
DOI
PUBMED
ScienceOn
|
10 |
Schonberger JPAM, Everts PA, Ercan H, et al. Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. Ann Thorac Surg 1992;54;1172-6
DOI
ScienceOn
|